Tag: anti-obesity drugs

Market News

New Data Boosts Lilly Obesity Pill Confidence Amid Market Shifts

New survey data gives fresh reasons to believe in Lilly's oral GLP-1 success story, even as rising yields and energy...

19/05/2026

8 views

Read More

Market News

High Dose Wegovy Delivers Stronger Weight Loss Results

New data on the higher dose of Wegovy reveals some patients losing almost 28% of their body weight. But who...

12/05/2026

5 views

Read More

Market News

Novo Nordisk CEO Signals Major Deals to Strengthen Obesity Drug Leadership

The head of Novo Nordisk just admitted they're more active than ever hunting for deals in the booming weight loss...

11/05/2026

10 views

Read More

Market News

Eli Lilly Stock Volatility After Earnings Surge Explained- Planning XML output with SEO title and markdown content.

Eli Lilly shares swung wildly after last week's big gains on earnings. One headline about its new oral drug triggered...

06/05/2026

12 views

Read More

Market News

Novo Nordisk OpenAI Partnership Boosts AI Drug Discovery

When a major player in the weight-loss drug space joins forces with a leader in artificial intelligence, the implications for...

14/04/2026

10 views

Read More

Market News

Eli Lilly Stock Slides on Bearish GLP-1 Outlook: Our Take

Eli Lilly's stock just took a 6% hit after analysts warned the GLP-1 obesity market might be overhyped—with smaller size...

19/03/2026

7 views

Read More

Altcoins

Top Stock Movers Midday: MOS, TME, DAL, UBER, LLY Surge or Slide

On March 17, 2026, stocks swung wildly midday—Mosaic and Delta soared while Tencent Music crashed over 20%. Geopolitical chaos in...

19/03/2026

10 views

Read More

Market News

Eli Lilly Downgrade: Is Obesity Drug Hype Overblown?

HSBC just slammed Eli Lilly with a rare downgrade, claiming the obesity drug boom is overhyped and the market won't...

19/03/2026

11 views

Read More

Altcoins

Novo Nordisk Downgrade: Semaglutide Patent Risks in 2026

TD Cowen just downgraded Novo Nordisk to Hold, slashing the price target as semaglutide patent losses loom in key markets....

10/03/2026

20 views

Read More

Global Companies

Eli Lilly Boosts Employer Coverage for Obesity Drugs

Eli Lilly just rolled out a program that could finally make powerful obesity medications affordable through your job's benefits. What...

05/03/2026

8 views

Read More